18 min listen
How a Clever Business Model May Accelerate the Use of Companion Diagnostics
FromThe Bio Report
ratings:
Length:
22 minutes
Released:
Oct 10, 2019
Format:
Podcast episode
Description
Scientists can understand individual tumors at a molecular basis, but clinician don’t yet routinely profile and treat cancers based on this knowledge. Strata Oncology, with drug developers as its customer, is providing tumor profiling to cancer patients in the hopes of directing them into appropriate clinical trials. We spoke to Dan Rhodes, co-founder and CEO of Strata, about the state of precision medicine, Strata’s business model which works around the often-difficult issue of reimbursement for in vitro diagnostics, and the company’s long-term plan for building a commercial diagnostics business.
Released:
Oct 10, 2019
Format:
Podcast episode
Titles in the series (100)
The Power of IBM’s Watson Is Coming to an App Near You: IBM’s Watson Group recently announced an investment in Pathway Genomics, part of a $100 million initiative by the computing giant to spur innovation in entrepreneurial companies that seek to leverage its cognitive computing platform Watson. Pathway G... by The Bio Report